Session Details

U063 Steroid Side Effects for Dermatologists: What a Practicing Clinician Needs to Know in a Fast-paced Clinic

Sun, Mar 10, 7:00 AM - 8:00 AM
Room 24C
1 CME Available Focus Session
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session will provide dermatologists with high-yield tips to effectively and efficiently manage steroid side effects in fast-paced dermatology clinics. This session will cover initiation of therapy, osteoporosis, infectious complications, and endocrine and GI complications.

LEARNING OBJECTIVES

1.

Predict what side effects are most likely to impact patients when starting therapy with systemic glucocorticoids; Outline steps that can be taken at the outset to proactively address these side effects and implement protective measures for bone health.

2.

Recognize that glucocorticoid use increases risk for infections; Assess risk factors for particular infectious complications including pneumocystis pneumonia and demonstrate knowledge of when to start PJP prophylaxis.

3.

Describe glucocorticoid dosing regimens that increase risk for adrenal insufficiency, and utilize tapering methods to reduce the risk for steroid withdrawal on cessation of therapy; Select preventative measures for reducing risk for peptic ulcer disease and GI bleed.

SCHEDULE

2:00 PM

Introduction to steroid side effects

Avrom Caplan, MD, FAAD

2:05 PM

Glucocorticoid induced osteoporosis, a Summary for dermatologists

Avrom Caplan, MD, FAAD

2:20 PM

Infections and Prophylaxis in Patients on Glucocorticoids

Robert Micheletti, MD, FAAD

2:35 PM

Endocrine, Gastric, and Assorted Steroid Side Effects

Victoria P. Werth, MD, FAAD

2:50 PM

Question and Answer

SPEAKERS

Avrom Caplan, MD, FAAD

Avrom Caplan, MD, FAAD

Robert Micheletti, MD, FAAD

Robert Micheletti, MD, FAAD

Victoria P. Werth, MD, FAAD

Victoria P. Werth, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Avrom Caplan, MD, FAAD

No financial relationships exist with ineligible companies.

Robert Micheletti, MD, FAAD

Acelyrin – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); InflaRx – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);

Victoria P. Werth, MD, FAAD

Alpine Immune Sciences – Consultant (1099 relationship)(Honoraria); Alumis – Consultant(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); arGEN-X – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); Biohaven – Consultant(Honoraria); BMS – Consultant(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); Corcept Therapeutics – Consultant(Honoraria); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kezar Life Sciences – Consultant(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Kyverna Therapeutics – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Mirobio – Consultant(Honoraria); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Octapharma – Consultant(Honoraria); Ono – Consultant(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); Scienomics – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Vertex Pharmaceuticals Incorporated – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria); Xencor – Consultant (1099 relationship)(Honoraria);